Wanting forward, the pharmaceutical offer chain is poised for continued evolution and transformation driven by technological breakthroughs, regulatory developments, and shifting industry dynamics. Various important tendencies and opportunities are more likely to form the way forward for the pharmaceutical source chain:Drugs are preferred primarily